Clinical Trials for Acral Melanoma

Find clinical trials for acral melanoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

A Beta-only IL-2 ImmunoTherapY Study

NCT ID: NCT05086692

This clinical trial, called the Beta-only IL-2 ImmunoTherapY Study, is looking to test a new treatment called MDNA11 for patients with advanced solid tumors, which are types of cancer that have spr...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Diego, California, United States, Baltimore, Maryland, United States +31 more

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

NCT ID: NCT06965231

This clinical trial is studying a new treatment approach for patients with stage II melanoma, a type of skin cancer. The researchers want to see if combining two medications, toripalimab (an immuno...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China, Shanghai, Shanghai, China +2 more

Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT ID: NCT04119024

This clinical trial is testing a new treatment for patients with advanced melanoma and other types of solid tumors that have spread in the body. The treatment involves using specially modified immu...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States, Los Angeles, California, United States +1 more

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

NCT ID: NCT05512481

This clinical trial is studying a combination of three medications—Camrelizumab, Apatinib, and Temozolomide—to see how effective they are as a treatment before surgery for patients with high-risk a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

NCT ID: NCT06661577

This clinical trial is studying a device called the LumAssure, which helps measure skin conditions to see if they are benign (not harmful) or cancerous. The goal is to find out how accurately this ...

Not yet recruiting

Type: observational Locations: Auckland, , New Zealand, Auckland, , New Zealand

Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma

NCT ID: NCT05789043

This clinical trial is studying a new treatment approach for advanced acral melanoma, a type of skin cancer. Researchers want to see how well a combination of three medications—Camrelizumab, Apatin...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, , China

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

NCT ID: NCT04331093

This clinical trial is studying a new treatment approach for acral melanoma, a type of skin cancer that primarily affects people with darker skin tones. The trial is looking at the combination of t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Changchun, Jilin, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions